High density lipoprotein (HDL) receptor activity was decreased by the addition of platelet-derived growth factor (PDGF) to cholesterol-loaded cultured human skin fibroblasts. Effects were observed within 12 hours, coinciding with Increases In trltlated thymldlne Incorporation Into DNA. The PDGF-medlated decrease In HDL binding was associated with a decrease In cholesterol efflux promoted by HDL 3 . PDGF exerted reciprocal effects on HDL and low density lipoprotein (LDL) receptor activity. With fibroblasts not loaded with cholesterol, PDGF Increased LDL binding without changing HDL receptor activity. With cholesterol-loaded cells, PDGF decreased HDL receptor activity without changing LDL receptor activity. These results show that a reduction In HDL receptor activity Is an additional cellular response to PDGF. Decreased HDL-medlated cholesterol efflux may result In retention of cholesterol needed for membrane synthesis In cells stimulated to proliferate. (Arteriosclerosis 7:325-332, July/August 1987)
and arterial smooth muscle cells in vitro. 5 In this study, we tested the hypothesis that PDGF in conjunction with an increase in cell proliferation decreases HDL binding and HDL-mediated cholesterol efflux.
Methods

Cells
Normal skin fibroblasts were grown from explants of punch biopsies of skin from the inner thigh of normal volunteers. Cells were grown in plastic tissue culture flasks in modified Dulbecco-Vogt medium containing 10% fetal bovine serum (growth medium) at 37° C, in humidified incubators equilibrated with 5% CO 2 ,95% air. Cells were trypsinized from stock flasks (2 to 8 passages) and were seeded in 35-mm plastic petri dishes using 2 ml of medium containing ~ 5 x 10 4 cells. After growing 5 to 7 days, cells were washed twice with phosphate-buffered saline (PBS)albumin mixture (0.2 g/l KCI, 0.2 g/l KH 2 PO 4 , 8.0 g/l NaCI, 2.16 g/l Na 2 HPO 4 -7H 2 O, 2.0 g/l bovine serum albumin; at pH 7.4) and incubated with serum-free culture medium containing 2.0 g/l albumin (serum-free medium) for 24 hours to synchronize cell growth (first incubation). Cells were then incubated from 4 to 24 hours in serum-free medium with or without PDGF (second incubation). To load cells with cholesterol, either nonlipoprotein cholesterol or low density lipoprotein (LDL) was added to the medium during either the first or second incubation. Nonlipoprotein cholesterol was dissolved in 95% ethanol (10 mg/ml) before addition to the albumin medium. LDL was added after the cells were incubated in lipoprotein-deficient serum for 48 hours to upregulate the LDL receptor. Since HDL binding has been shown to be affected by changes in cholesterol esterification in cells, 6 
Llpoprotelns and Lipoproteln-Deflclent Serum
Lipoproteins were isolated from human serum by refrigerated sequential ultracentrifugation (LDL, d = 1.019 to 1.063; HDL 3 , d = 1.125 to 1.210). 8 Lipoproteins were iodinated by the McFarlane monochloride procedure as modified for lipoproteins. 9 Specific activity ranged from 300 to 500 cpm/ng protein for 125 I-HDL 3 and 100 to 200 cpm/ng protein for 12S I-LDL. LJpoprotein-deficient serum was prepared from the infranatant of human serum subjected to ultracentrifugation at d = 1.25. 2
Preparation of Partially Purified PDGF
PDGF purified by methods previously described 10 was kindly supplied by Russell Ross, and was used in a concentration of 2 to 10 ng/ml. In selected experiments, partially purified PDGF (0.4% purity) was used in place of the purified PDGF. 10 Both preparations had similar effects on HDL receptor activity.
Binding of 125 I-HDL 3 to Cells
To determine cell binding of 125 I-HDL 3 at 37° C, cells were rapidly washed twice with PBS-albumin (wash medium) and incubated at 37° C with serum-free medium containing 2.0 mg/ml bovine serum albumin and, unless otherwise indicated, 5 /ug/ml 125 I-HDL 3 plus or minus 100 jtg/ml unlabelled HDL 3 . After 1 hour, dishes were chilled on ice, washed rapidly three times with ice-cold wash medium, incubated twice for 10 minutes with the same medium, and washed twice again rapidly with cold wash medium containing no albumin. 11 Cells were then digested in 0.1 N NaOH, an aliquot was assayed for 12S I radioactivity, and another aliquot was assayed for protein content. 12 When the assay was performed at 0° C, cells were washed twice at room temperature and chilled to 0° C while bathed with the second wash medium. Cells were then incubated at 0° C with serum-free medium containing no bicarbonate, 20 mM HEPES (pH 7.4), 2.0 mg/ml albumin, and 12S I-HDL 3 plus or minus excess unlabelled HDL 3 . After either 2 or 3 hours, cells were washed seven times by the same procedure used for the 37° C binding assay and digested with NaOH. 11 The degree of regulation of HDL binding by PDGF and cholesterol 3 was similar when the assays were performed at either temperature. Receptor-bound HDL 3 is defined as high-affinity binding calculated as the difference between binding of 125 I-HDL 3 in the absence and presence of excess unlabelled HDL 3 . Treatment of cells with PDGF had no significant effect on binding of 125 I-HDL 3 in the presence of 20-to 100-fold excess unlabelled HDL 3 (lowaffinity binding).
Trltlated Cholesterol Efflux
Subconfluent fibroblasts were washed and sterols were loaded with either 3 H-cholesterol or LDL reconstituted with 3 H-cholesterol linoleate. For loading with nonlipoprotein 3 H-cholesterol, cells were incubated for 36 hours with serum-free medium containing the indicated concentration of 3 H-cholesterol added in ethanol, washed twice with wash buffer, and then incubated for 18 hours with serum-and cholesterol-free medium (plus albumin) to allow for equilibration of intracellular cholesterol pools and internalization of surface-bound cholesterol. For loading with LDL reconstituted with 3 H-cholesteryl linoleate, cells were first incubated for 48 hours with lipoprotein-deficient serum to upregulate LDL receptors and then incubated for 24 hours with serum-free albumin medium plus ACAT inhibitor and reconstituted LDL (20 /tg protein/ml, 20 to 30 cpm 3 H/ng protein). LDL was reconstituted with 3 H-cholesteryl linoleate by the microemulsion exchange method of Craig et al. 11 -13 After the loading protocol, cells were incubated for 18 to 24 hours with serum-and cholesterol-free albumin medium with or without PDGF.
To assay the rate of efflux of 3 H-cholesterol from cells, fibroblasts were washed twice with PBS-albumin and subsequently incubated for 6 hours with medium containing 1 mg/ml albumin plus the indicated concentration of unlabelled HDL 3 (10 /xg/ml). The cells were then chilled on ice, the media was collected and centrifuged to sediment detached cells, and the radioactivity was assayed by liquid scintillation counting. HDL 3 -mediated cholesterol efflux is defined as the difference in the amount of tritiated radioactivity appearing in the medium in the presence and absence of HDL 3 . Cellular lipids were extracted from washed cells by the hexane-isopropanol method described by Brown et al. 1 1 1 4 and separated by thin-layer chromatography. 11 The total cellular cholesterol mass was assayed by the cholesterol oxidase method. 1115 Since an ACAT inhibitor was routinely included in the medium, over 90% of the cellular cholesterol was in the free form.
Efflux of Endogenously Synthesized Cholesterol
Confluent fibroblasts were loaded with LDL sterol (30 fig protein/ml) as described in the previous section except that the LDL did not contain radiolabelled sterol. Cells were then washed and incubated for 18 hours in serum-and lipoprotein-free medium with or without PDGF. To radiolabel intracellular pools of cholesterol, cells were then pulsed with 3 H-mevalonolactone for 6 hours at 15° C. At this temperature, cells synthesize 3 H-cholesterol in microsomal membranes, but transfer of newly synthesized cholesterol to plasma membrane is inhibited. 18 ' 17 3 H-mevalonolactone was used as a precursor, since it bypasses the hydroxylmethylglutaryl CoA reductase step In cholesterol biosynthesis which is suppressed in cholesterol-loaded cells.
For the pulse incubations, cells were chilled, washed twice, and incubated with serum-free medium containing albumin, ACAT inhibitor, and 0.4 mM 3 H-mevalonolactone (10 jtCi/ml) in a 15° C water bath. After 6 hours the cells were chilled on ice, washed five times with cold PBS, and each dish received prewarmed (room temperature) medium containing 1 mg/ml albumin, ACAT inhibitor, and the indicated concentrations of PDGF and HDL 3 (efflux incubation). After 4 hours at 37° C, dishes were chilled on ice, the media were collected, cells were washed once with cold PBS, and the wash was combined with media. After centrifugation at 800 g for 10 minutes (5° C) to sediment
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the detached cells, the media plus wash were treated with chloroform/methanol (2:1 vol/vol) to extract lipids, the lipid classes were separated by thin-layer chromatography, 11 and unesterified cholesterol was quantified by liquid scintillation counting. Cellular lipids were extracted, isolated, and assayed as described earlier.
Other Methods
Tritiated thymidine incorporation was measured at various times after the addition of PDGF by the method of Pollack and Vogel 18 as previously described. 19 Tritiated thymidine was added to cells at 2.5 /iCi/ml in serum-free medium without albumin for a 2-hour incubation at 37° C. Binding of 12S I-LDL to fibroblasts was determined by the same procedure used for the 37° C assay of 125 I-HDL 3 binding. The cell number was determined by counting trypsin-released cells in a hemacytometer. Data analysis was performed with Student's f test and analysis of variance. The intraassay coefficient of variation for HDL binding at 0°C was 13.6%.
Results
To assess the effects of a growth factor on the rate of upregulation of HDL receptors, fibroblasts were incubated in a cholesterol-enriched medium in the presence or absence of PDGF. PDGF appeared to limit the stimulation of HDL binding activity by cholesterol treatment ( Figure 1A ). The effect of PDGF was significant (p<0.02) by analysis of variance for the time points between 9 and 24 hours. The reduction of HDL binding coincided with an increase in tritiated thymidine incorporation into DNA ( Figure 1B) .
PDGF appeared to exert reciprocal effects on HDL and LDL receptor activities ( Figure 2 ). In fibroblasts not loaded with cholesterol (left panel), the addition of PDGF stimulated LDL receptor activity (p<0.001). Under these conditions, HDL receptor activity was low and unchanged by PDGF treatment. When cells were cholesterol-loaded (right panel), the HDL receptor activity was increased. Under these conditions, PDGF decreased HDL receptor activity (p<0.002), while LDL receptor activity was unaffected.
To exclude the possibility that PDGF could be affecting cholesterol delivery to cells, in all subsequent experiments cells were preincubated with cholesterol-enriched medium for 24 hours before exposure to cholesterol-free medium containing PDGF. Previous studies (unpublished) have shown that, after upregulation of HDL binding by cholesterol loading, subsequent incubations for 24 hours with cholesterol-free medium that lacked acceptors for cholesterol resulted in little change in the cell unesterified cholesterol content, provided cholesterol esterification was inhibited by an ACAT inhibitor. During this second incubation with cholesterol-free medium, HDL receptor activity continued to increase slightly. Addition of PDGF during the second incubation inhibited HDL receptor activity after 12 hours of incubation ( Figure 3A ) (p<0.01 by analysis of variance for time points between 12 and 24 hours) in association with increased tritiated thymidine incorporation into DNA ( Figure 3B ). The results from other experiments using the same protocol demonstrated that treatment of cells with PDGF for 18 hours resulted in a 12% increase in cell number and a 23 ± 12% (mean ± SD) increase in protein content (data not shown).
Both the PDGF-mediated decrease in HDL binding activity and the increase in thymidine incorporated into DNA were dose-dependent ( Figure 4 ). When cholesterol-loaded cells were incubated with medium containing increasing concentrations of PDGF, HDL binding activity decreased (p<0.01 by regression analysis) in parallel with the increased incorporation of thymidine into DNA.
PDGF treatment decreased HDL binding at all HDL 3 concentrations tested ( Figure 5 ). Both Scatchard 20 and Wolff linearization plots 21 The PDGF-mediated decrease in HDL binding was associated with a decrease in the ability of HDL 3 to promote cholesterol efflux from cells. When cells were preincubated for 24 hours with medium containing increasing concentrations of tritiated cholesterol followed by 18-hour in-cubations with cholesterol-free medium, both HDL binding activity ( Figure 6A , solid line) and tritiated cholesterol efflux ( Figure 6B ) increased in association with the increase in cellular tritiated cholesterol ( Figure 6C ). Addition of PDGF to the medium (dashed line) during the 18-hour incubation with cholesterol-free medium dampened the effects of cholesterol on HDL receptor activity (p<0.01) and on HDL 3 -mediated cholesterol efflux (p<0.04). Neither cellular tritiated cholesterol ( Figure 6C Figure 4 . preincubated with serum-free medium plus albumin, ACAT inhibitor, and nonlipoprotein cholesterol (30 g/ml) for 24 hours before Incubation in the same medium containing no cholesterol and the indicated concentration of purified PDGF. After 18 hours, HDL binding (A) and 3 H-thymldlne incorporation into DNA (B) were measured as described in Methods. merit in this experiment. The effect of PDGF on cholesterol efflux was less pronounced than the corresponding effect on HDL binding. However, values for HDL binding represent high-affinity interaction, whereas the cholesterol efflux assay reflects both high-and low-affinity processes.
To test the effects of PDGF on the HDL-mediated efflux of cholesterol delivered into cells by a physiologic process, cells were cholesterol-loaded with LDL reconstituted with 3 H-cholesteryl linoleate prior to the efflux assay (see Methods). Previous studies demonstrated that delivery of cho- Figure 5 . Effect of PDGF on saturation curves for HDL3 binding to cholesterol-loaded cells. Fibroblasts were preincubated with serum-free medium, albumin, ACAT inhibitor, and nonlipoprotein cholesterol (30 jig/ml) for 24 hours before incubation in serumfree medium, albumin, ACAT inhibitor, with (o) or without (•) PDGF for 18 hours. Cells were washed and incubated for 3 hours at 0° C with medium containing increasing concentrations of 1 2 S I-HDL3. Specific HDL binding activity was determined as in Methods. lesterol into cells via the LDL receptor pathway led to a modest increase in HDL receptor activity. 3 Current studies indicate that PDGF treatment of fibroblasts previously exposed to LDL significantly reduced HDL receptor activity (32 ± 9%; mean ± SD for three separate experiments). The ratio of unestertfled cholesterol to protein in cells loaded with LDL sterol also was reduced 27% by PDGF treatment largely due to an increase in protein content per dish in response to PDGF treatment.
When cholesterol efflux from cells loaded with LDL sterol was measured as a function of HDL 3 concentration, the saturation curve for cells not treated with PDGF exhibited both high-affinity (saturable at 20 jug/ml HDL 3 ) and lowaffinity (nonsaturable up to 100 /xg/ml HDL 3 ) components (Figure 7) . Treatment of cells with PDGF reduced cholesterol efflux from cells at all HDL 3 concentrations measured, and this occurred whether results were expressed as percent cell radioactivity ( Figure 7A ) or as mass equivalents of unesterified cholesterol per mg cell protein ( Figure 7B ). PDGF treatment reduced the high-affinity component of cholesterol efflux to the greatest extent, suggesting that PDGF specifically reduced HDL receptor-mediated cholesterol efflux without markedly affecting receptor-independent efflux.
To test the effects of PDGF on the removal of cholesterol from cellular pools other than those associated with the plasma membrane, intracellular pools of cholesterol were specifically labelled by treatment of cholesterol-loaded cells with 3 H-mevalonolactone at 15° C (see Methods). With this procedure, cells synthesize cholesterol in microsomal membranes but are unable to transport this newly synthesized sterol to the plasma membrane until cells are warmed to 37° C. 16 When cells loaded with LDL sterol were Effects of PDGF on HDL receptor activity and HDLmediated cholesterol efflux. Fibroblasts were preincubated for 24 hours in serum-free medium plus albumin containing increasing concentrations of tridated cholesterol before incubation In serumfree medium In the presence (o) or absence (•) of partially purified PDGF (10 ng/ml) for 18 hours. A. Cells were washed and then incubated for 2 hours at 0° C with medium containing 10 ^tg/ml 125 I-HDL 3 with or without 100 jig/ml HDL 3 . HDL receptor activity was determined as previously described. B. Cells were washed and then incubated for 6 hours at 37° C with serum-free medium, albumin (0.1 mg %), ACAT inhibitor with (o) or without (•) PDGF (10 ng/ml) in the presence or absence of HDL 3 (10 /xg/ml). HDLmediated cholesterol efflux was determined as described In Methods. C. Tritlated cell cholesterol content was measured as described in Methods. pulse-incubated with 3 H-mevalonolactone at 15° C and then incubated at 37° C with medium containing increasing concentrations of HDL 3 , efflux of endogenously labelled cholesterol was markedly reduced by treatment of cells with PDGF (Rgure 8). This reduction was evident whether results were expressed as percent cellular radioactivity ( Figure 8A ) or equivalents of cellular unesterified free cholesterol mass ( Figure 8B) .
As with efflux of LDL-derived 3 H-cholesterol, the saturation curves for efflux of endogenously labelled cholesterol demonstrate that only the high-affinity component of HDLpromoted efflux was reduced by treatment of cells with PDGF. These results provide additional support for the concept that PDGF affects only the receptor-mediated removal of cholesterol from cells by HDL 3 .
Discussion
HDL receptor activity in extrahepatic, nonsteroidogenic cells, previously shown to be regulated by cellular cholesterol content, 3 ' 48 also appears to be a function of the growth state of the cell. Within 18 hours after the cholesterol-loaded cells were incubated with PDGF, cell number and tritiated thymidine were increased, while HDL receptor activity was decreased. The combined results from six experiments demonstrated that cholesterol treatment caused a 109 ± 15% (mean ± SEM) increase in HDL binding in the absence of PDGF and only a 41 ± 4% increase in binding in the presence of PDGF (p<0.01 by paired /test). Thus, induction of HDL receptors by cholesterol loading was reduced by more than 60% when growth was stimulated by PDGF. PDGF treatment caused a similar decrease in HDL binding in human arterial smooth muscle cells (unpublished data).
The saturation curves for 125 I-HDL 3 binding to cholesterol-loaded cells demonstrated that PDGF caused a decrease in high-affinity binding. Analysis by linearization methods revealed that this change in high-affinity binding was due to a decrease in the maximum binding capacity rather than in binding affinity, suggesting that the number of HDL receptors on the cell surface was reduced in the presence of PDGF. This reduction in receptor number was ?. 0.6 Fibroblasts were Incubated as described in Figure 7 , except that unlabelled LDL was used in the loading Incubation, and intracellular membranes were specifically radlolabelled with 3 H-cholesterol by pulse-incubation of cells for 6 hours at 15° C with medium containing 3 H-mevalonolactone immediately preceding the HDL 3 efflux incubation (see Methods). Values for cellular free cholesterol In the presence and absence of PDGF, respectively, were 2.5 ± 0.2 and 3.0 ± 0.6 cpm x lO^mg cell protein (radioactivity) and 38 ± 3 and 29 ± 2 /ig/mg cell protein (mass).
associated with a decrease in the ability of HDL 3 to promote cholesterol efflux from cells. PDGF treatment caused a striking reduction in the ability of HDL 3 to remove cholesterol from intracellular pools. This reduction appeared to be exclusively due to the suppression of the receptor-HDL interaction, since it occurred under conditions where receptor-independent efflux of cholesterol was unaffected by PDGF. These results are consistent with the hypotheses that: 1) HDL receptors facilitate removal of cholesterol from cells, and 2) that PDGF acts to promote retention of intracellular pools of cholesterol for cell membrane synthesis.
The mechanism behind the PDGF-induced decrease in HDL receptor activity is not known. One possibility is that the increase in the cellular demand for cholesterol for the synthesis of new membranes leads to cholesterol depletion in cellular pools that regulate receptor synthesis. Tabas and Tall 22 suggested that HDL binds to membrane lipids, particularly cholesterol, rather than receptor proteins, raising the possibility that PDGF reduces HDL binding by lowering membrane cholesterol content. Although the unesterified cholesterol-to-protein ratio in cells was reduced when cells were exposed long enough to PDGF to allow significant cell growth, the suppression of HDL receptor activity by PDGF was still evident under conditions where little change in cell cholesterol content was observed (see Figure 6 ). Moreover, PDGF treatment appeared to reduce HDL-mediated removal of cholesterol from intracellular pools to a greater extent than from plas-ma membranes. Therefore, it seems unlikely that a decrease in plasma membrane cholesterol per se could account for the dampened receptor-HDL interactions observed. However, the possibility that PDGF specifically reduces the cholesterol content of membrane domains that bind HDL 3 cannot be excluded.
Under the experimental conditions used in the present study, PDGF treatment caused only a modest increase (two™ to fourfold) in incorporation of thymidine in DNA. Several factors could account for this apparently slow mitogenic activity of PDGF. First, to minimize the effect of PDGF on actual cell growth and proliferation that follows an increased DNA synthesis, incubation times were limited to less than 24 hours. Whereas this length of time was sufficient to detect significant changes in HDL receptor activity, it preceded the maximum stimulation of DNA synthesis by PDGF. Second, to exclude acceptors for cellular cholesterol from the medium, the cells were incubated in the absence of serum which contains "progression" factors that would have potentiated the mitogenic action of PDGF. Third, since serum growth factors can avidly bind to cells, it is possible that control cells were not completely quiescent even several days after removal of serum from the medium.
It has been postulated that release of PDGF from adherent platelets at the site of vascular endothelial cell damage may contribute to atherogenesis by stimulation of smooth muscle cell proliferation. The results from the current and previous studies suggest that PDGF also may contribute to foam cell formation. First, PDGF stimulates cholesterol delivery to cells by increasing receptor-dependent 7 ' 19 and receptor-independent 23 uptake of LDL. Second, PDGF promotes cholesterol biosynthesis. 1924 Third, PDGF enhances cholesteryl esterification in cultured fibroblasts. 7 Fourth, results in the present study demonstrate that PDGF also suppresses HDL receptor-mediated cholesterol efflux from cells even under conditions where cholesterol esterification in cells is blocked by an ACAT inhibitor. Therefore, by what appear to be independent mechanisms, the exposure of cells to PDGF simultaneously enhances the uptake of LDL cholesterol, increases cholesterol synthesis, decreases receptor-mediated removal of cholesterol from cells by HDL, and increases the ability of cells to estertfy intracellular cholesterol. This combined action of PDGF could potentiate the accumulation of cholesteryl ester in arterial cells and promote foam cell formation.
